Twenty-First Century Fox, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Twenty-First Century Fox, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C10185
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:メディア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Twenty-First Century Fox, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Twenty-First Century Fox, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Twenty-First Century Fox, Inc. (21st Century Fox or “the company”) is a diversified global media and entertainment company. The company holds a portfolio of broadcast, cable, film, satellite assets and pay-television (TV). It’s assets include FX, FOX, FXX, Fox news channel, FS1, FXM, National Geographic channels, Fox Sports Network, Fox Business Network, Star India and FOX Sports. 21st Century Fox has its operations across Asia, Europe, North America and Latin America. The company is headquartered in New York City, New York, the US.

Scope

- Detailed information on Twenty-First Century Fox, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Twenty-First Century Fox, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Twenty-First Century Fox, Inc. including a breakdown and examination of key business segments
- Intelligence on Twenty-First Century Fox, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Twenty-First Century Fox, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Twenty-First Century Fox, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Twenty-First Century Fox, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Twenty-First Century Fox, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Twenty-First Century Fox, Inc.: Company Overview 9
Twenty-First Century Fox, Inc.: Overview and Key Facts 9
Twenty-First Century Fox, Inc.: Overview 9
Twenty-First Century Fox, Inc.: Key Facts 9
Twenty-First Century Fox, Inc.: Key Employees 10
Twenty-First Century Fox, Inc.: Key Employee Biographies 12
Twenty-First Century Fox, Inc.: Major Products and Services 19
Twenty-First Century Fox, Inc.: Company History 20
Twenty-First Century Fox, Inc.: Management Statement 28
Twenty-First Century Fox, Inc.: Locations and Subsidiaries 30
Twenty-First Century Fox, Inc.: Key Competitors 31
Twenty-First Century Fox, Inc.: Company Analysis 32
Twenty-First Century Fox, Inc.: Business Description 32
Twenty-First Century Fox, Inc.: SWOT Analysis 35
Twenty-First Century Fox, Inc.: SWOT Overview 35
Twenty-First Century Fox, Inc.: Strengths 35
Twenty-First Century Fox, Inc.: Weaknesses 36
Twenty-First Century Fox, Inc.: Opportunities 36
Twenty-First Century Fox, Inc.: Threats 38
Twenty-First Century Fox, Inc.: Corporate Financial Deals Activity 41
Twenty-First Century Fox, Inc.: Financial Deals Overview 41
Twenty-First Century Fox, Inc.: Targets and Partners 43
Twenty-First Century Fox, Inc.: Top Deals 2014 – 2018YTD* 45
Twenty-First Century Fox, Inc.: Advisors 46
Twenty-First Century Fox, Inc.: Top Legal Advisors 46
Twenty-First Century Fox, Inc.: Top Financial Advisors 46
Twenty-First Century Fox, Inc.: Mergers and Acquisitions 47
Twenty-First Century Fox, Inc.: Corporate Venturing 48
Twenty-First Century Fox, Inc.: Partnership 49
Twenty-First Century Fox, Inc.: Divestments 50
Twenty-First Century Fox, Inc.: Private Equity and Ownership 51
Twenty-First Century Fox, Inc.: Recent Developments 52
Twenty-First Century Fox, Inc.: News and Events Summary 52
Twenty-First Century Fox, Inc.: Business Expansion 55
Twenty-First Century Fox, Inc.: Corporate Governance 55
Twenty-First Century Fox, Inc.: Financial Performance 56
Twenty-First Century Fox, Inc.: Market Developments 57
Twenty-First Century Fox, Inc.: Strategy and Operations 57
Appendix 59
Contact Us 59
Methodology 59
About MarketLine 60

List of Tables
Table 1: Twenty-First Century Fox, Inc.: Key Facts
Table 2: Twenty-First Century Fox, Inc.: Key Employees
Table 3: Twenty-First Century Fox, Inc.: Company History
Table 4: Twenty-First Century Fox, Inc.: Locations and Subsidiaries
Table 5: Twenty-First Century Fox, Inc.: Key Competitors
Table 6: Twenty-First Century Fox, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Twenty-First Century Fox, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Twenty-First Century Fox, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Twenty-First Century Fox, Inc.: Targets and Partners
Table 10: Twenty-First Century Fox, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Twenty-First Century Fox, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Twenty-First Century Fox, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Twenty-First Century Fox, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Twenty-First Century Fox, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Twenty-First Century Fox, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Twenty-First Century Fox, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Twenty-First Century Fox, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 18: Twenty-First Century Fox, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 19: Twenty-First Century Fox, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 20: Twenty-First Century Fox, Inc.: Divestments by Geography (2014 - YTD*2018)
Table 21: Twenty-First Century Fox, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 22: Twenty-First Century Fox, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 23: Twenty-First Century Fox, Inc.: News and Events Summary
Table 24: Twenty-First Century Fox, Inc.: Business Expansion
Table 25: Twenty-First Century Fox, Inc.: Corporate Governance
Table 26: Twenty-First Century Fox, Inc.: Financial Performance
Table 27: Twenty-First Century Fox, Inc.: Market Developments
Table 28: Twenty-First Century Fox, Inc.: Strategy and Operations

List of Figures
Figure 1: Twenty-First Century Fox, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Twenty-First Century Fox, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Twenty-First Century Fox, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Twenty-First Century Fox, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Twenty-First Century Fox, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Twenty-First Century Fox, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Twenty-First Century Fox, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 8: Twenty-First Century Fox, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Twenty-First Century Fox, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 10: Twenty-First Century Fox, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 11: Twenty-First Century Fox, Inc.: Divestments by Geography (2014 - YTD*2018)
Figure 12: Twenty-First Century Fox, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 13: Twenty-First Century Fox, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Twenty-First Century Fox, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clevexel Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Clevexel Pharma SAS (Clevexel) is a drug development company that develops drugs to treat diseases of the central nervous system. The company’s pipeline product portfolio includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease patien …
  • The Techint Group:企業の戦略・SWOT・財務情報
    The Techint Group - Strategy, SWOT and Corporate Finance Report Summary The Techint Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mobile Telesystems
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Fidelity Life Assurance of Zimbabwe Ltd:企業の戦略・SWOT・財務情報
    Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Zealand Pharma AS (ZEAL):製薬・医療:M&Aディール及び事業提携情報
    Summary Zealand Pharma AS (Zealand) is a biotechnology company that discovers, designs and develops peptide based medicines that targets specialty diseases. The company’s marketed products comprise Lyxumia and Suliqua for the treatment of Type 2 diabetes and others for the treatment of obesity and f …
  • Yantai Jereh Oilfield Services Group Co Ltd (002353):石油・ガス:M&Aディール及び事業提携情報
    Summary Yantai Jereh Oilfield Services Group Co Ltd (Yantai Jereh), formerly Yantai Jereh Equipment Group Co Ltd is an integrated oil and gas company that manufactures, designs, and markets oilfield equipment. The company offers oil and gas field equipment such as drilling and workover rig, simulati …
  • The National Commercial Bank
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Pioneer Corp:企業の戦略的SWOT分析
    Pioneer Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Goodrich Petroleum Corp (GDP):企業の財務・戦略的SWOT分析
    Goodrich Petroleum Corp (GDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Hexion Inc.:企業の戦略・SWOT・財務分析
    Hexion Inc. - Strategy, SWOT and Corporate Finance Report Summary Hexion Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sumitomo Mitsui Banking Corp:企業の戦略・SWOT・財務情報
    Sumitomo Mitsui Banking Corp - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Banking Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Alligator Bioscience AB (ATORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Alligator Bioscience AB (Alligator Bioscience) is a clinical-stage biotechnology company that discovers and develops antibody based pharmaceuticals for the treatment of cancer. The company’s pipeline products include ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527. The ADC-1013, currently und …
  • MEI Pharma Inc (MEIP):企業の財務・戦略的SWOT分析
    MEI Pharma Inc (MEIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Faes Farma SA (FAE):企業の財務・戦略的SWOT分析
    Faes Farma SA (FAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Tata Motors Limited:企業の戦略・SWOT・財務分析
    Tata Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Yissum Research Development Company of the Hebrew University of Jerusalem Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC) is a technology transfer company that offers marketing the inventions and know-how generated by the University's researchers and students. The company’s products include exelon, doxil, cherry tomatoes and lo …
  • Taiwan Semiconductor Manufacturing Company Limited:企業の戦略・SWOT・財務情報
    Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report Summary Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Voyager Therapeutics Inc (VYGR):企業の財務・戦略的SWOT分析
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …
  • Baloise Holding Ltd (BALN):企業の財務・戦略的SWOT分析
    Baloise Holding Ltd (BALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Novelis Inc
    Novelis Inc - Strategy, SWOT and Corporate Finance Report Summary Novelis Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆